Second-generation micro-bypass stent significantly lowers IOP, medication intake

WARSAW, Poland — Results of the Micro-Invasive Glaucoma Surgery Study Group with the second-generation trabecular micro-bypass iStent inject implanted with a single-use injector showed a significant decrease in IOP and number of medications with a favorable safety outcome.The iStent inject (Glaukos) is single-piece, miniature, collar button-shaped heparin-coated titanium stent, implanted ab interno into Schlemm’s canal. Multiple lateral lumens are designed to provide an exit route for the aqueous from the anterior chamber, Manfred Tetz, MD, explained at the winter meeting of the European Society of Cataract and Refractive Surgeons. “Results (Read more...)

Full Story →